TRIB3 and colonic neoplasm: Research has shown that TRIB3 physically interacts with β‐catenin and activates it in various types of tumors.[39, 40, 41] Co‐IP revealed that TRIB3 interacts with β‐catenin in colon cancer cells (Figure 4H).